Intracystic therapies for cystic craniopharyngioma in childhood

Frontiers in Endocrinology

Volumn 3, Issue MAR, 2012, Pages

  Bartels, Ute ^a   Laperriere, Normand ^b   Bouffet, Eric ^a   Drake, James ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Bleomycin; Children; Craniopharyngioma; Interferon; Intracystic therapy; Radioisotopes

Indexed keywords

EID: 84874406528     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2012.00039     Document Type: Article

References (61)

1. Albright, A. L., Hadjipanayis, C. G., Lunsford, L. D., Kondziolka, D., Pollack, I. F., and Adelson, P. D. (2005). Individualized treatment of pediatric craniopharyngiomas. Childs Nerv. Syst. 21,649-654.
2. Alen, J. F., Boto, G. R., Lagares, A., de la Lama, A., Gomez, P. A., and Lobato, R. D. (2002). Intratumoural bleomycin as a treatment for recurrent cystic craniopharyngioma. Case report and review of the literature. Neurocirugia (Astur) 13, 479-485; discussion 485.
3. Backlund, E. O. (1973). Studies on craniopharyngiomas. 3. Stereotaxic treatment with intracystic yttrium-90. Acta Chir. Scand. 139,237-247.
4. Backlund, E. O. (1989). Colloidal radioisotopes as part of a multi-modality treatment of craniopharyngiomas. J. Neurosurg. Sci. 33, 95-97.
5. Barriger, R. B., Chang, A., Lo, S. S., Timmerman, R. D., DesRosiers, C., Boaz, J. C., and Fakiris, A. J. (2011). Phosphorus-32 therapy for cystic craniopharyngiomas. Radio-ther. Oncol. 98,207-212.
6. Becker, G., Kortmann, R. D., Skalej, M., and Bamberg, M. (1999). The role of radiotherapy in the treatment of craniopharyngioma-indications, results, side effects. Front. Radiat. Ther. Oncol. 33,100-113.
7. Belen, D., Er, U., Yigitkanli, K., and Bolay,H. (2007). Delayedneurotoxic complication of intracavitary bleomycin therapy for craniopharyngioma in a child who had previously undergone radiosurgery. Case report. J. Neurosurg. 106, 391-393.
8. Blackburn, T. P., Doughty, D., and Plowman, P. N. (1999). Stereotactic intracavitary therapy of recurrent cystic craniopharyngioma by instillation of 90yttrium. Br. J. Neurosurg. 13,359-365.
9. Caceres, A. (2005). Intracavitary therapeutic options in the management of cystic craniopharyngioma. Childs Nerv. Syst. 21,705-718.
10. Cavalheiro, S., Dastoli, P. A., Silva, N. S., Toledo, S., Lederman, H., and da Silva, M. C. (2005). Use of interferon alpha in intratumoral chemotherapy for cystic craniopharyngioma. Childs Nerv. Syst. 21, 719-724.
11. Cavalheiro, S., Di Rocco, C., Valen-zuela, S., Dastoli, P. A., Tambur-rini, G., Massimi, L., Nicacio, J. M., Faquini, I. V., Ierardi, D. F., Silva, N. S., Pettorini, B. L., and Toledo, S. R. (2010). Craniopharyngiomas: intratumoral chemotherapy with interferon-alpha: a multicen-ter preliminary study with 60 cases. Neurosurg. Focus 28, E12.
12. Cavalheiro, S., Sparapani, F. V., Franco, J. O., da Silva, M. C., and Braga, E M. (1996). Use of bleomycin in intratumoral chemotherapy for cystic craniopharyngioma. Case report. J. Neurosurg. 84, 124-126.
13. Derrey, S., Blond, S., Reyns, N., Touzet, G., Carpentier, P., Gauthier, H., and Dhellemmes, P. (2008). Management of cystic craniopharyngiomas with stereotactic endocavitary irradiation using colloidal 186Re: a retrospective study of 48 consecutive patients. Neurosurgery 63, 1045-1052; discussion 1052-1043.
14. Floyd, J. R., Cmelak, A., Russell, P., and Weaver, K. D. (2009). Endoscopic, image-guided, transnasal instillation of (32)P for recurrent infrachi-asmatic cystic craniopharyngioma. Minim. Invasive Neurosurg. 52, 137-140.
15. Franzini, A., Leocata, F., Pintucci, M., and Broggi, G. (2001). Cystic craniopharyngioma: Stereotactic intracavitary Bleomycin administration. [Italian] La somministrazione di Bleomicina intracavitaria nel trat-tamento chirurgico del craniofarin-gioma cistico. Rivista Medica 7, 41-45.
16. Gascon, G. G. (2003). Randomized treatment study of inosi-plex versus combined inosiplex and intraventricular interferon-alpha in subacute sclerosing panencephali-tis (SSPE): international multicen-ter study. J. Child Neurol. 18, 819-827.
17. Hader, W. J., Steinbok, P., Hukin, J., and Fryer, C. (2000). Intratumoral therapy with bleomycin for cystic craniopharyngiomas in children. Pediatr. Neurosurg. 33, 211-218.
18. Haisa, T., Ueki, K., and Yoshida, S. (1994). Toxic effects of bleomycin on the hypothalamus following its administration into a cystic craniopharyngioma. Br. J. Neurosurg. 8, 747-750.
19. Hargrave, D. R. (2006). Does chemotherapy have a role in the management of craniopharyngioma? J. Pediatr. Endocrinol. 19(Suppl. 1), 407-412.
20. Hasegawa, T., Kondziolka, D., Hadjipanayis, C. G., and Lunsford, L. D. (2004). Management of cystic craniopharyngiomas with phosphorus-32 intracavitary irradiation. Neurosurgery 54, 813-820; discussion 820-812.
21. Hechtman, C. D., Li, Z., Mansur, D. B., Perez, C. A., Myerson, R. J., Simpson, J. R., Anders, J. C., Wu, C., and Palucci, C. A. (2005). Dose distribution outside of a sphere of P-32 chromic phosphorous colloid. Int. J. Radiat. Oncol. Biol. Phys. 63, 961-968.
22. Hellwig, D., Bauer, B. L., and List-Hellwig, E. (1995). Stereotactic endoscopic interventions in cystic brain lesions. Acta Neurochir. Suppl. 64, 59-63.
23. Hernandez, J., Morel, C., Gonzalez, A., Garcia, S., Hernandez, M., and Zarate, A. (2002). Use of bleomycin through a local reservoir in patients with cystic craniopharyngiomas. [Spanish] Uso de la bleomicina mediante un reservorio local en pacientes con craneofaringiomas quisticos. Medicina Interna de Mexico 18, 273-277.
24. Hsu, T. R., Chang, K. P., and Wong, T. T. (2009). Intracystic bleomycin therapy for craniopharyngioma in children. Neuro-oncology 11,902.
25. Hukin, J., Steinbok, P., Lafay-Cousin, L., Hendson, G., Strother, D., Mercier, C., Samson, Y., Howes, W., and Bouf-fet, E. (2007). Intracystic bleomycin therapy for craniopharyngioma in children: the Canadian experience. Cancer 109,2124-2131.
26. Hukin, J., Visser, J., Sargent, M., God-dard, K., Fryer, C., and Steinbok, P. (2005). Childhood craniopharyngioma: Vancouver experience. Childs Nerv. Syst. 21,758-765.
27. Ierardi, D., Pinhal, M. A., Coelho, B. V., Martins, J. R., Thomazini-Gouveia, J., Silva, N. S., De Toledo, S. R. C., and Cavalheiro, S. (2009). Expression analysis of hialuronic acid sin-tases and hyaluronidases in craniopharyngiomas tissue and quantification of hyaluronic acid in intratu-moral liquid during alpha interferon chemotherapy. Pediatr. Blood Cancer 53, 826-827.
28. Ierardi, D. F., Fernandes, M. J., Silva, I. R., Thomazini-Gouveia, J., Silva, N. S., Dastoli, P., Toledo, S. R., and Cavalheiro, S. (2007). Apoptosis in alpha interferon (IFN-alpha) intra-tumoral chemotherapy for cystic craniopharyngiomas. Childs Nerv. Syst. 23,1041-1046.
29. Ingraham, F. D., and Scott, H. W. Jr. (1946). Craniopharyngiomas in children. J. Pediatr. 29, 95-116.
30. Jakacki, R. I., Cohen, B. H., Jamison, C., Mathews, V. P., Arenson, E., Longee, D. C., Hilden, J., Cornelius, A., Needle, M., Heilman, D., Boaz, J. C., and Luerssen, T. G. (2000). Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas. J. Neurosurg. 92, 255-260.
31. Jiang, R., Liu, Z., and Zhu, C. (2002). Preliminary exploration of the clinical effect of bleomycin on craniopharyngiomas. Stereotact. Funct. Neurosurg. 78, 84-94.
32. Joki, T., Oi, S., Babapour, B., Kaito, N., Ohashi, K., Ebara, M., Kato, M., and Abe, T. (2002). Neuroendoscopic placement of Ommaya reservoir into a cystic craniopharyngioma. Childs Nerv. Syst. 18, 629-633.
33. Julow, J., Backlund, E. O., Lanyi, F., Hajda, M., Balint, K., Nyary, I., and Szeifert, G. T. (2007). Long-term results and late complications after intracavitary yttrium-90 colloid irradiation of recurrent cystic craniopharyngiomas. Neurosurgery 61, 288-295; discussion 295-286.
34. Kim, S. -D., Park, J. -Y., Park, J., Lee, J. -B., Kim, S. -H., and Lim, D. -J. (2007). Radiological findings following postsurgical intratumoral bleomycin injection for cystic craniopharyngioma. Clin. Neurol. Neurosurg. 109,236-241.
35. Kramer, S., McKissock, W., and Con-cannon, J. P. (1961). Craniopharyngiomas. Treatment by combined surgery and radiation therapy. J. Neurosurg. 18,217-226.
36. Kubo, O., Takakura, K., Miki, Y., Okino, T., and Kitamura, K. (1974). Intracystic therapy of bleomycin for craniopharyngioma-effect of bleomycin for cultured craniopharyngioma cells and intracystic concentration of bleomycin (author's transl). No Shinkei Geka 2, 683-688.
37. Lafay-Cousin, L., Bartels, U., Raybaud, C., Kulkarni, A. V., Guger, S., Huang, A., and Bouffet, E. (2007). Neuro-radiological findings of bleomycin leakage in cystic craniopharyngioma. Report of three cases. J. Neurosurg. 107,318-323.
38. Linnert, M., and Gehl, J. (2009). Bleomycin treatment of brain tumors: an evaluation. Anticancer Drugs 20, 157-164.
39. Louis, D. N., Ohgaki, H., Wiestler, O. D., and Cavenee, W. K. (2007). WHO classification of tumours of the central nervous system. International Agency for Research on Cancer, Lyon.
40. Merchant, T. E., Kiehna, E. N., Kun, L. E., Mulhern, R. K., Li, C., Xiong, X., Boop, F. A., and Sanford, R. A. (2006). Phase II trial of con-formal radiation therapy for pedi-atric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. J. Neurosurg. 104, 94-102.
41. Mottolese, C., Stan, H., Hermier, M., Berlier, P., Convert, J., Frappaz, D., and Lapras, C. (2001). Intracystic chemotherapy with bleomycin in the treatment of craniopharyngiomas. Childs Nerv. Syst. 17, 724-730.
42. Mottolese, C., Szathmari, A., Berlier, P., and Hermier, M. (2005). Craniopharyngiomas: our experience in Lyon. ChildsNerv. Syst. 21, 790-798.
43. Müller, H. L. (2010). Childhood craniopharyngioma-current concepts in diagnosis, therapy and follow-up. Nat. Rev. Endocrinol. 6, 609-618.
44. Müller, H. L., Albanese, A., Calami-nus, G., Hargrave, D., Garre, M. L., Gebhardt, U., Saran, F., Sorensen, N., and Spoudeas, H. A. (2006). Consensus and perspectives on treatment strategies in childhood craniopharyngioma: results of a meeting of the Craniopharyngioma Study Group (SIOP),Genova, 2004. J. Pediatr. Endocrinol. Metab. 19(Suppl. 1), 453-454.
45. Musolino, A., Munari, C., Blond, S., Betti, O., Lajat, Y., Schaub, C., Askienazy, S., and Chodkiewicz, J. P. (1985). Stereotaxic treatment of expanding cysts in craniopharyngiomas by endocavitary beta-irradiation (Re-186; Au-198; Y-90). Neurochirurgie 31,169-178.
46. Park, D. H., Park, J. Y., Kim, J. H., Chung, Y. G., Lee, H. K., Lee, K. C., and Suh, J. K. (2002). Outcome of postoperative intratumoral bleomycin injection for cystic craniopharyngioma. J. Korean Med. Sci. 17,254-259.
47. Park, Y. S., Chang, J. H., Park, Y G., and Kim, D. S. (2011). Recurrence rates after neuroendoscopic fenestration and gamma knife surgery in comparison with subtotal resection and gamma knife surgery for the treatment of cystic craniopharyngiomas. J. Neurosurg. 114, 1360-1368.
48. Pettorini, B. L., Inzitari, R., Massimi, L., Tamburrini, G., Caldarelli, M., Fanali, C., Cabras, T., Messana, I., Castagnola, M., and Di Rocco, C. (2010). The role of inflammation in the genesis of the cystic component of craniopharyngiomas. ChildsNerv. Syst. 26, 1779-1784.
49. Pettorini, B. L., Tamburrini, G., Massimi, L., Caldarelli, M., and Di Rocco, C. (2009). Endoscopic trans-ventricular positioning of intracystic catheter for treatment of craniopharyngioma. Technical note. J. Neurosurg. Pediatr. 4, 245-248.
50. Pollock, B. E., Lunsford, L. D., Kondzi-olka, D., Levine, G., and Flickinger, J. C. (1995). Phosphorus-32 intracavitary irradiation of cystic craniopharyngiomas: current technique and long-term results. Int. J. Radiat. Oncol. Biol. Phys. 33, 437-446.
51. Sadeghi, M., Moradi, S., Shahzadi, S., andPourbeigi, H. (2007). Dosimetry of (32)P radiocolloid for treatment of cystic craniopharyngioma. Appl. Radiat. Isot. 65,519-523.
52. Sanford, R. A. (1994). Craniopharyngioma: results of survey of the American Society of Pediatric Neurosurgery. Pediatr. Neurosurg. 21(Suppl. 1), 39-43.
53. Savas, A., Arasil, E., Batay, F., Sel-cuki, M., and Kanpolat, Y. (1999). Intracavitary chemotherapy of polycystic craniopharyngioma with bleomycin. Acta Neurochir. (Wien) 141, 547-548; discussion 549.
54. Savas, A., Erdem, A., Tun, K., and Kanpolat, Y (2000). Fatal toxic effect of bleomycin on brain tissue after intracystic chemotherapy for a craniopharyngioma: case report. Neurosurgery 46, 213-216; discussion 216-217.
55. Stefanou, A., and Siderov, J. (2001). Medical errors. Dosage nomenclature of bleomycin needs to be standardised to avoid errors. BMJ 322, 1423-1424.
56. Steinbok, P., and Hukin, J. (2010). Intracystic treatments for craniopharyngioma. Neurosurgery 28, E13.
57. Takahashi, H., Nakazawa, S., and Shimura, T. (1985). Evaluation of postoperative intratumoral injection of bleomycin for craniopharyngioma in children. J. Neurosurg. 62, 120-127.
58. Takahashi, H., Yamaguchi, F., and Teramoto, A. (2005). Long-term outcome and reconsideration of intracystic chemotherapy with bleomycin for craniopharyngioma in children. Childs Nerv. Syst. 21, 701-704.
59. Voges, J., Sturm, V., Lehrke, R., Treuer, H., Gauss, C., and Berthold, F. (1997). Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereo-tactically applied colloidal beta-emitting radioactive sources. Neurosurgery 40, 263-269; discussion 269-270.
60. Yang, S. H., Kim, I. S., Hong, J. T., Sung, J. H., Son, B. C., and Lee, S. W (2009). Intratumoral bleomycin injection as a primary therapy for cystic craniopharyngioma. Neuro-oncology 11, 903.
61. Zanon, N., Cavalheiro, S., and da Silva, M. C. (2008). Does the choice of surgical approach to insert an intratumoral catheter influence the results of intratumoral cystic treatment? Surg. Neurol. 70, 66-69; discussion 69.